On track to S$1 billion net profit this year, this company clinches US$3.1 billion new orders in 3Q |
This small-cap can clinch big orders as far away as Latin America. Stock's up 157% year-to-date |
IX BIOPHARMA: Clinches crucial outlicensing deal with Nasdaq pharma |
YANGZIJIANG: Clinches US$1.3 billion of contracts |
ISDN: Clinches first customer, Centurion, for dormitory disinfectants |
FEDERAL INTERNATIONAL: Clinches 5 contracts worth US$58.4 m |